Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Jung Choi. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Jung Choi zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:ANNX / Annexon, Inc. | Director | 33 000 |
| US:GBT / Global Blood Therapeutics Inc. | See Remarks | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Jung Choi. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera ANNX / Annexon, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w ANNX / Annexon, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | ANNX | Choi Jung | 33 000 | 4,1900 | 33 000 | 4,1900 | 138 270 | 52 | 6.9600 | 91 410 | 66,11 |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera ANNX / Annexon, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w ANNX / Annexon, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Jung Choi ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-03 |
|
4 | ANNX |
Annexon, Inc.
Common Stock |
P - Purchase | 33 000 | 33 000 | 4,19 | 138 270 | 138 270 | ||
| 2022-10-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -25 000 | 0 | -100,00 | ||||
| 2022-10-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -226 672 | 0 | -100,00 | ||||
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
G - Gift | -73 855 | 226 672 | -24,58 | ||||
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 674 | 300 527 | 0,90 | 3,40 | 9 092 | 1 021 792 | |
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 674 | 300 527 | 0,90 | 3,40 | 9 092 | 1 021 792 | |
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 74 964 | 295 179 | 34,04 | 3,40 | 254 878 | 1 003 609 | |
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 275 | 220 215 | 1,04 | 65,82 | 149 740 | 14 494 551 | |
| 2022-09-29 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 16 902 | 217 940 | 8,41 | 16,40 | 277 193 | 3 574 216 | |
| 2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -1 861 | 201 038 | -0,92 | 68,15 | -126 827 | 13 700 740 | |
| 2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 208 | 202 899 | 1,10 | ||||
| 2022-09-06 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 763 | 200 691 | 1,40 | ||||
| 2022-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -2 126 | 197 928 | -1,06 | 32,40 | -68 882 | 6 412 867 | |
| 2022-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 145 | 200 054 | 3,17 | ||||
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to buy) |
A - Award | 28 628 | 28 628 | |||||
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 17 668 | 17 668 | |||||
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 17 668 | 17 668 | |||||
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 763 | 16 577 | -14,29 | ||||
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -956 | 191 374 | -0,50 | 29,87 | -28 556 | 5 716 341 | |
| 2022-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 763 | 192 330 | 1,46 | ||||
| 2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 020 | 12 080 | -20,00 | ||||
| 2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 6 250 | -33,33 | ||||
| 2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 0 | -100,00 | ||||
| 2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 340 | 189 567 | -1,73 | 29,33 | -97 962 | 5 560 000 | |
| 2022-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 192 907 | 4,91 | ||||
| 2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 020 | 15 100 | -16,67 | ||||
| 2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 9 375 | -25,00 | ||||
| 2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 2 875 | -50,00 | ||||
| 2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 743 | 182 367 | -2,01 | 27,33 | -102 296 | 4 984 090 | |
| 2021-09-24 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 186 110 | 5,09 | ||||
| 2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 762 | 19 340 | -12,50 | ||||
| 2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -1 370 | 183 887 | -0,74 | 29,85 | -40 894 | 5 489 027 | |
| 2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 762 | 185 257 | 1,51 | ||||
| 2021-09-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 128 | 182 495 | 0,07 | 24,39 | 3 122 | 4 451 053 | |
| 2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 020 | 15 100 | -16,67 | ||||
| 2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 9 375 | -25,00 | ||||
| 2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 2 875 | -50,00 | ||||
| 2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 743 | 182 367 | -2,01 | 27,33 | -102 296 | 4 984 090 | |
| 2021-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 9 020 | 186 110 | 5,09 | ||||
| 2021-06-04 |
|
4 | ANNX |
Annexon, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 22 102 | 22 102 | |||||
| 2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 38 739 | 38 739 | |||||
| 2021-03-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 140 | 177 090 | 0,08 | 36,21 | 5 069 | 6 412 429 | |
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 020 | 18 120 | -14,29 | ||||
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 12 500 | -20,00 | ||||
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 5 750 | -33,33 | ||||
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 063 | 0 | -100,00 | ||||
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -4 646 | 176 950 | -2,56 | 49,49 | -229 931 | 8 757 256 | |
| 2021-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 13 083 | 181 596 | 7,76 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 020 | 21 140 | -12,50 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 15 625 | -16,67 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 8 625 | -25,00 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 062 | 4 063 | -49,99 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -6 239 | 168 513 | -3,57 | 67,48 | -421 008 | 11 371 257 | |
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 13 082 | 174 752 | 8,09 | ||||
| 2020-08-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 162 | 161 670 | 0,10 | 36,68 | 5 942 | 5 930 056 | |
| 2020-06-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 42 400 | 42 400 | |||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 38 500 | 38 500 | |||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 24 160 | 24 160 | |||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 18 750 | -14,29 | ||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 11 500 | -20,00 | ||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 063 | 8 125 | -33,34 | ||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 570 | 161 508 | -2,16 | 65,26 | -232 978 | 10 540 012 | |
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 10 063 | 165 078 | 6,49 | ||||
| 2020-02-04 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 286 | 155 015 | 0,18 | 36,68 | 10 490 | 5 685 950 | |
| 2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -2 479 | 154 729 | -1,58 | 76,88 | -190 586 | 11 895 566 | |
| 2019-12-17 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 5 000 | 157 208 | 3,28 | ||||
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -3 125 | 21 875 | -12,50 | ||||
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 14 375 | -16,67 | ||||
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 062 | 12 188 | -25,00 | ||||
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 990 | 152 208 | -2,55 | 54,25 | -216 458 | 8 257 284 | |
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 10 062 | 156 198 | 6,89 | ||||
| 2019-08-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 285 | 146 136 | 0,20 | 36,68 | 10 454 | 5 360 268 | |
| 2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 000 | 5 000 | -28,57 | ||||
| 2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -692 | 145 851 | -0,47 | 58,51 | -40 489 | 8 533 742 | |
| 2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 146 543 | 1,38 | ||||
| 2019-04-10 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 269 | 144 543 | 0,19 | 36,68 | 9 867 | 5 301 837 | |
| 2019-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 277 | 144 274 | 0,19 | 35,53 | 9 842 | 5 126 055 | |
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 17 250 | -14,29 | ||||
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 063 | 16 250 | -20,00 | ||||
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 25 000 | 25 000 | |||||
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 40 000 | 40 000 | |||||
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -2 515 | 143 997 | -1,72 | 48,44 | -121 827 | 6 975 215 | |
| 2019-02-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 938 | 146 512 | 4,97 | ||||
| 2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 875 | 20 125 | -12,50 | ||||
| 2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 062 | 20 313 | -16,66 | ||||
| 2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -3 440 | 139 574 | -2,41 | 43,15 | -148 436 | 6 022 618 | |
| 2018-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 6 937 | 143 014 | 5,10 | ||||
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 2 675 | -18,35 | ||||
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 2 675 | -18,35 | ||||
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -198 | 74 964 | -0,26 | ||||
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 136 077 | -1,02 | 48,25 | -67 550 | 6 565 715 |
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 477 | 0,44 | 3,40 | 2 043 | 467 422 | |
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 477 | 0,44 | 3,40 | 2 043 | 467 422 | |
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 136 275 | 0,15 | 3,40 | 673 | 463 335 | |
| 2018-05-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 136 077 | -1,16 | 48,25 | -77 200 | 6 565 715 |
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 3 276 | -15,50 | ||||
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 3 276 | -15,50 | ||||
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -198 | 75 162 | -0,26 | ||||
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 137 677 | -1,01 | 45,50 | -63 700 | 6 264 304 |
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 077 | 0,43 | 3,40 | 2 043 | 472 862 | |
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 077 | 0,43 | 3,40 | 2 043 | 472 862 | |
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 137 875 | 0,14 | 3,40 | 673 | 468 775 | |
| 2018-04-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 137 677 | -1,15 | 45,50 | -72 800 | 6 264 304 |
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 3 877 | -13,42 | ||||
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 3 877 | -13,42 | ||||
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -198 | 75 360 | -0,26 | ||||
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 139 277 | -1,00 | 54,15 | -75 810 | 7 541 850 |
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 140 677 | 0,43 | 3,40 | 2 043 | 478 302 | |
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 140 677 | 0,43 | 3,40 | 2 043 | 478 302 | |
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 139 475 | 0,14 | 3,40 | 673 | 474 215 | |
| 2018-03-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 139 277 | -1,14 | 54,15 | -86 640 | 7 541 850 |
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 4 478 | -11,83 | ||||
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -601 | 4 478 | -11,83 | ||||
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
M - Exercise | -198 | 75 558 | -0,26 | ||||
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 140 877 | -0,98 | 62,95 | -88 130 | 8 868 207 |
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 142 277 | 0,42 | 3,40 | 2 043 | 483 742 | |
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 142 277 | 0,42 | 3,40 | 2 043 | 483 742 | |
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 141 075 | 0,14 | 3,40 | 673 | 479 655 | |
| 2018-02-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 140 877 | -1,12 | 62,95 | -100 720 | 8 868 207 |
| 2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 000 | 7 000 | -22,22 | ||||
| 2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -692 | 142 477 | -0,48 | 62,30 | -43 112 | 8 876 317 | |
| 2018-02-16 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 143 169 | 1,42 | ||||
| 2018-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 676 | 135 931 | 0,50 | 13,69 | 9 254 | 1 860 895 | |
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 23 000 | 23 000 | |||||
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 35 000 | 35 000 | |||||
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 063 | 24 375 | -14,29 | ||||
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -1 405 | 140 058 | -0,99 | 59,60 | -83 738 | 8 347 457 | |
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 4 063 | 141 463 | 2,96 | ||||
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 000 | 9 000 | -18,18 | ||||
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -692 | 137 400 | -0,50 | 57,90 | -40 067 | 7 955 460 | |
| 2018-02-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 138 092 | 1,47 | ||||
| 2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 000 | 11 000 | -15,38 | ||||
| 2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -686 | 136 092 | -0,50 | 58,15 | -39 891 | 7 913 750 | |
| 2018-01-26 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 136 778 | 1,48 | ||||
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | -601 | 5 079 | -10,58 | ||||
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | -601 | 5 079 | -10,58 | ||||
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
M - Exercise | -198 | 75 756 | -0,26 | ||||
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 134 778 | -1,17 | 52,85 | -84 560 | 7 123 017 |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 136 378 | -1,02 | 52,85 | -73 990 | 7 207 577 |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 778 | 0,44 | 3,40 | 2 043 | 468 445 | |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 137 778 | 0,44 | 3,40 | 2 043 | 468 445 | |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 136 576 | 0,15 | 3,40 | 673 | 464 358 | |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -2 000 | 13 000 | -13,33 | ||||
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -877 | 136 378 | -0,64 | 52,10 | -45 692 | 7 105 294 | |
| 2018-01-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 2 000 | 137 255 | 1,48 | ||||
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 5 680 | -9,57 | ||||
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 5 680 | -9,57 | ||||
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 75 954 | -0,26 | ||||
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 135 255 | -1,02 | 36,55 | -51 170 | 4 943 570 |
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 136 655 | 0,44 | 3,40 | 2 043 | 464 627 | |
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 136 655 | 0,44 | 3,40 | 2 043 | 464 627 | |
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 135 453 | 0,15 | 3,40 | 673 | 460 540 | |
| 2017-12-20 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 135 255 | -1,17 | 36,55 | -58 480 | 4 943 570 |
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 6 281 | -8,73 | ||||
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 6 281 | -8,73 | ||||
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 76 152 | -0,26 | ||||
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 136 855 | -1,01 | 39,75 | -55 650 | 5 439 986 |
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 138 255 | 0,44 | 3,40 | 2 043 | 470 067 | |
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 138 255 | 0,44 | 3,40 | 2 043 | 470 067 | |
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 137 053 | 0,14 | 3,40 | 673 | 465 980 | |
| 2017-11-21 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 136 855 | -1,16 | 39,75 | -63 600 | 5 439 986 |
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 6 882 | -8,03 | ||||
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 6 882 | -8,03 | ||||
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 76 350 | -0,26 | ||||
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 138 455 | -1,00 | 32,65 | -45 710 | 4 520 556 |
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 855 | 0,43 | 3,40 | 2 043 | 475 507 | |
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 139 855 | 0,43 | 3,40 | 2 043 | 475 507 | |
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 138 653 | 0,14 | 3,40 | 673 | 471 420 | |
| 2017-10-18 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 138 455 | -1,14 | 32,65 | -52 240 | 4 520 556 |
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 7 483 | -7,43 | ||||
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 7 483 | -7,43 | ||||
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 76 548 | -0,26 | ||||
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 140 055 | -0,99 | 30,00 | -42 000 | 4 201 650 |
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 141 455 | 0,43 | 3,40 | 2 043 | 480 947 | |
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 141 455 | 0,43 | 3,40 | 2 043 | 480 947 | |
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 140 253 | 0,14 | 3,40 | 673 | 476 860 | |
| 2017-10-02 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 140 055 | -1,13 | 30,00 | -48 000 | 4 201 650 |
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 8 084 | -6,92 | ||||
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 8 084 | -6,92 | ||||
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 76 746 | -0,26 | ||||
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 141 655 | -0,98 | 30,00 | -42 000 | 4 249 650 |
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 143 055 | 0,42 | 3,40 | 2 043 | 486 387 | |
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 143 055 | 0,42 | 3,40 | 2 043 | 486 387 | |
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 141 853 | 0,14 | 3,40 | 673 | 482 300 | |
| 2017-09-05 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 141 655 | -1,12 | 30,00 | -48 000 | 4 249 650 |
| 2017-08-14 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 15 000 | 15 000 | |||||
| 2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
M - Exercise | -4 062 | 28 438 | -12,50 | ||||
| 2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
F - Taxes | -1 527 | 145 790 | -1,04 | 25,10 | -38 328 | 3 659 329 | |
| 2017-08-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 4 062 | 147 317 | 2,84 | ||||
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 8 685 | -6,47 | ||||
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -601 | 8 685 | -6,47 | ||||
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy) |
M - Exercise | -198 | 76 944 | -0,26 | ||||
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 400 | 143 255 | -0,97 | 30,00 | -42 000 | 4 297 650 |
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 144 655 | 0,42 | 3,40 | 2 043 | 491 827 | |
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 601 | 144 655 | 0,42 | 3,40 | 2 043 | 491 827 | |
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
M - Exercise | 198 | 143 453 | 0,14 | 3,40 | 673 | 487 740 | |
| 2017-07-25 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
S - Sale | X | -1 600 | 143 255 | -1,10 | 30,00 | -48 000 | 4 297 650 |
| 2017-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 658 | 144 855 | 0,46 | 13,73 | 9 034 | 1 988 859 | |
| 2017-02-14 |
|
5 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 591 | 144 197 | 0,41 | 15,20 | 8 983 | 2 191 794 | |
| 2017-01-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
| 2017-01-19 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Restricted Stock Units |
A - Award | 32 500 | 32 500 | |||||
| 2016-10-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 9 286 | 9 286 | |||||
| 2016-03-14 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy) |
A - Award | 9 286 | 9 286 | |||||
| 2016-03-14 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 749 | 143 606 | 0,52 | 16,09 | 12 051 | 2 310 621 | |
| 2016-03-14 |
|
4/A | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
P - Purchase | 25 000 | 25 000 | 20,00 | 500 000 | 500 000 | ||
| 2016-02-03 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
A - Award | 749 | 168 606 | 0,45 | 16,09 | 12 051 | 2 712 871 | |
| 2016-01-07 |
|
4 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
P - Purchase | 25 000 | 167 857 | 17,50 | 20,00 | 500 000 | 3 357 140 | |
| 2015-08-11 | 3 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
285 714 | ||||||||
| 2015-08-11 | 3 | GBT |
Global Blood Therapeutics, Inc.
Common Stock |
285 714 |
